Genmab To Offer $1.5B Of Senior Secured Notes Due 2032 And $1B Of Senior Unsecured Notes Due 2033, The Company Also Launched The Syndication Of A New $2B Senior Secured Term Loan In Addition To A $1B Senior Secured Term Loan Facility And $500M Senior Secured Revolving Credit Facility To Finance The Merus Acquisition
Benzinga Newsdesk 1 year ago
BiotechM&ANewsHealth CareFinancingGeneral
Full article content is not available on this page. Continue to benzinga.com to read the original report.